Low HDL Cholesterol Is a Risk Factor for Deficit and Decline in Memory in Midlife
- 1 August 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 28 (8) , 1556-1562
- https://doi.org/10.1161/atvbaha.108.163998
Abstract
Objective— The purpose of this study was to examine the relationship between fasting serum lipids and short-term verbal memory in middle-aged adults. Methods and Results— Total cholesterol, high-density lipoprotein cholesterol (HDL-C), triglycerides, and memory were measured twice, at mean ages 55 and 61, in 3673 male and female participants of the Whitehall II study. Short-term verbal memory was assessed using a 20-word list. Logistic regression was used to model associations between ATP-III categories of lipids and memory deficit (recall of ≤4 words) and decline (decrease of ≥2 words). Analyses were adjusted for education, occupational position, coronary heart disease, stroke, hypertension, use of medication, diabetes, smoking, and alcohol consumption. Compared to high HDL-C (≥60 mg/dL), low HDL-C (<40 mg/dL) was associated with greater odds of memory deficit at the first (OR=1.27; 95% confidence interval [CI]=0.91 to 1.77) and second wave of this study (OR=1.53; 95% CI=1.04 to 2.25) in fully adjusted a... We examined the relationship between fasting serum lipids and short-term verbal memory in middle-aged adults. Low HDL cholesterol and decreasing levels over a 5-year follow-up period were associated with poor memory and decline in memory, respectively. No other lipid that was tested was associated with memory.Keywords
This publication has 40 references indexed in Scilit:
- Serum cholesterol changes after midlife and late-life cognitionNeurology, 2007
- The Metabolic Syndrome and Alzheimer DiseaseArchives of Neurology, 2007
- Twenty-six–Year Change in Total Cholesterol Levels and Incident DementiaArchives of Neurology, 2007
- Metabolic Syndrome and Cognitive Function: A Population-Based Follow-Up Study in Elderly WomenDementia and Geriatric Cognitive Disorders, 2006
- Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based studyPublished by Elsevier ,2006
- Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trialActa Neurologica Scandinavica, 2006
- Cholesterol as a risk factor for Alzheimer's disease - epidemiological evidenceActa Neurologica Scandinavica, 2006
- High-Density Lipoprotein Cholesterol and Ischemic Stroke in the ElderlyJAMA, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Serum cholesterol, APOE genotype, and the risk of Alzheimer’s disease: A population-based study of African AmericansNeurology, 2000